IPP Bureau
Unichem Laboratories sale its stake in Optimus Drugs
By IPP Bureau - September 24, 2022
The company has received payment towards completion of sale of the first tranche from Sekhmet Pharmaventures Private Limited.
Cadila and CII launches joint national campaign for rabies-free India by 2030
By IPP Bureau - September 24, 2022
Rabies claims around 59,000 deaths globally a year, of which around 20,000 or just over one-third of the deaths take place in India alone
JB Pharma rolls out its campaign #Heart2HeartChallengeIndia
By IPP Bureau - September 24, 2022
The #Heart2HeartChallengeIndia campaign is very simple – you have to climb 60 steps in a minute, make a video of it, share it on your social media, tag 5 people, inviting them to take this challenge to check their heart health
Bausch and Glenmark announce approval of RYALTRIS in Canada
By IPP Bureau - September 24, 2022
RYALTRIS is a fixed-dose combination therapy that provides relief for the symptoms of SAR, both nasal and ocular, in one easy-to-use nasal spray
Snazzy launches scan box and remote monitoring app to achieve 100% orthodontic goals
By IPP Bureau - September 24, 2022
The startup plans to provide free technology to dental clinics upon registration.
Madhavbaug plans to foray in UAE, Europe & US
By IPP Bureau - September 24, 2022
To set up 50 lifestyle modification centres across the UAE in the next 24 months
India achieves significant landmark in reduction of child mortality rates
By IPP Bureau - September 24, 2022
The country has been witnessing a progressive reduction in IMR, U5MR and NMR
19 crore AB-PMJAY cards created; 3.8 crore beneficiaries avails free benefit
By IPP Bureau - September 24, 2022
AB PMJAY has been successful in providing quality health services to the beneficiaries who come from weak financial backgrounds
Lupin receives approval from US FDA for Diclofenac Sodium Topical Solution USP
By IPP Bureau - September 23, 2022
Diclofenac Sodium Topical Solution USP, 2% w/w (RLD Pennsaid) had estimated annual sales of US $484 million in the US
Shilpa Medicare Hyderabad facility receives US FDA clearance
By IPP Bureau - September 23, 2022
The facility is identified as a testing laboratory in numerous ANDAs filed by Shilpa Medicare Limited and its agreed parties
U.S. District Court rules in favor of Merck in Sitagliptin Phosphate patent lawsuit
By IPP Bureau - September 23, 2022
Sitagliptin is an active ingredient in JANUVIA, JANUMET and JANUMET XR
Lynparza approved in China as first-line maintenance treatment with Bevacizumab for HRD- positive advanced ovarian cancer
By IPP Bureau - September 23, 2022
One in two women with advanced ovarian cancer has an HRD-positive tumor
KRSNAA leverages AI to deliver quality diagnostics to the rural hinterlands of India
By IPP Bureau - September 23, 2022
Krsnaa Diagnostics plans to set up Tele-Pathology Reporting Centre in Pune
Cipla receives EIR for Indore plant, Aurbindo for Raleigh
By IPP Bureau - September 23, 2022
The plant at Raleigh, North Carolina, USA owned by Aurolife Pharma has received an establishment inspection report (EIR)
KDAH receives SMART ICU certification after pandemic
By IPP Bureau - September 23, 2022
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
